Introduction
Skin conditions can sometimes appear suddenly and cause significant concern, especially when they involve painful red lesions, swelling, or fever. One rare but important inflammatory disorder doctors may encounter is Sweet syndrome, also known as acute febrile neutrophilic dermatosis.
Although uncommon, this condition can develop quickly and produce tender, red plaques or bumps on the skin, often affecting the face, neck, arms, or upper body. The good news is that when diagnosed early, treatment can lead to rapid improvement within days.
This article explains a real clinical presentation, how doctors diagnose the condition, possible triggers, and the most effective treatment approaches used in modern dermatology.
Case Presentation
A patient presented with sudden, painful erythematous lesions on the face and neck. Due to the rapid onset and discomfort, the patient was urgently referred to dermatology for further evaluation.
Because the symptoms appeared shortly after starting a new medication, physicians suspected a drug-related inflammatory reaction. As a precaution, the recently introduced medication was immediately discontinued.
Doctors then initiated a comprehensive diagnostic evaluation to determine the cause of the skin eruption.
Diagnostic Workup
To identify the underlying condition and rule out other possible disorders, clinicians performed several tests, including:
• Skin biopsy
• Complete blood count (CBC)
• Antibody testing
• Lupus anticoagulant testing
• Additional serological markers
While awaiting laboratory confirmation, physicians started oral corticosteroid therapy to control inflammation and reduce symptoms.
Within 48 hours, the patient experienced significant improvement. The painful lesions began to fade, and discomfort subsided quickly.
Laboratory Findings
Further laboratory results revealed several important findings:
• Leukocytosis (elevated white blood cell count)
• Neutrophilia (high neutrophil levels)
• Positive antibodies and lupus anticoagulant
• Negative routine serology results
Later, the skin biopsy confirmed the diagnosis of Sweet syndrome, validating the initial clinical suspicion.
What Is Sweet Syndrome?
Sweet syndrome is a rare inflammatory skin disorder characterized by:
• Sudden onset of painful red plaques or nodules
• Fever or systemic symptoms in some cases
• Dense infiltration of neutrophils in the skin
• Rapid response to corticosteroid therapy
The condition was first described by dermatologist Robert Douglas Sweet in 1964, which is why it carries his name.
Causes and Risk Factors
The exact cause of Sweet syndrome is not fully understood. However, researchers believe it involves immune system dysregulation and cytokine-driven activation of neutrophils.
Several factors may trigger the condition:
Infections
Bacterial or viral infections can sometimes precede the development of Sweet syndrome.
Malignancies
Certain cancers—especially hematologic cancers—may be associated with the disorder.
Medications
Drug-induced Sweet syndrome is relatively common and may occur after exposure to medications such as:
• Antibiotics
• Antiepileptic drugs
• Hormonal contraceptives
• Antihypertensive medications
• Vaccines
• Colony-stimulating factors
Autoimmune or Inflammatory Conditions
Some patients develop Sweet syndrome alongside systemic inflammatory disorders.
Common Symptoms
Symptoms can develop rapidly, often within a few days.
Typical signs include:
• Painful red or purple skin plaques
• Tender bumps on the face, neck, or arms
• Fever or flu-like symptoms
• Fatigue or malaise
• Skin swelling or inflammation
The lesions are often highly sensitive to touch and may appear suddenly without warning.
Differential Diagnosis
Because several skin conditions can mimic its appearance, doctors must rule out other possible disorders before confirming the diagnosis.
Conditions considered during evaluation include:
• Urticaria (hives)
• Contact dermatitis
• Drug eruptions (toxicoderma)
• Cutaneous lupus
A skin biopsy combined with laboratory findings is typically required for a definitive diagnosis.
Treatment and Management
The first-line treatment for Sweet syndrome is systemic corticosteroid therapy.
Common treatments include:
Oral Corticosteroids
These medications rapidly reduce inflammation and usually produce improvement within 24–72 hours.
Discontinuation of Triggering Drugs
If a medication caused the reaction, stopping the drug is essential.
Additional Therapies
In patients who cannot take corticosteroids, doctors may consider alternative treatments such as:
• Anti-inflammatory medications
• Immunosuppressive drugs
• Targeted therapies for underlying diseases
Prognosis
Most patients experience rapid relief once treatment begins, particularly with corticosteroids.
However, recurrence can occur, especially when Sweet syndrome is associated with:
• Chronic inflammatory conditions
• Underlying malignancies
• Persistent triggering medications
Long-term management focuses on treating the underlying cause and monitoring for recurrence.
Key Clinical Takeaways
• Sweet syndrome is a rare inflammatory skin disorder with sudden onset.
• It often presents with painful red plaques and systemic inflammation.
• Diagnosis requires clinical evaluation, laboratory testing, and skin biopsy.
• Oral corticosteroids are the most effective first-line treatment.
• Identifying underlying triggers such as medications or systemic disease is critical.
Medical Disclaimer
This article is intended for educational and informational purposes only. It does not replace professional medical advice, diagnosis, or treatment.
If you experience sudden painful skin lesions, fever, or unexplained inflammation, consult a qualified healthcare professional for proper evaluation.
